CN1899350A - Traditional Chinese medicine for preventing subcutaneous bleeding after needle withdrawal - Google Patents
Traditional Chinese medicine for preventing subcutaneous bleeding after needle withdrawal Download PDFInfo
- Publication number
- CN1899350A CN1899350A CNA2006100453308A CN200610045330A CN1899350A CN 1899350 A CN1899350 A CN 1899350A CN A2006100453308 A CNA2006100453308 A CN A2006100453308A CN 200610045330 A CN200610045330 A CN 200610045330A CN 1899350 A CN1899350 A CN 1899350A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- needle withdrawal
- preventing
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 206010018999 Haemorrhage subcutaneous Diseases 0.000 title 1
- 208000032843 Hemorrhage Diseases 0.000 claims abstract description 15
- 239000004863 Frankincense Substances 0.000 claims abstract description 10
- 238000007920 subcutaneous administration Methods 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 15
- 241000180649 Panax notoginseng Species 0.000 claims description 15
- 241000717739 Boswellia sacra Species 0.000 claims description 9
- 241001057584 Myrrha Species 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 13
- 239000000843 powder Substances 0.000 abstract description 6
- 238000007796 conventional method Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 230000000202 analgesic effect Effects 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 235000009161 Espostoa lanata Nutrition 0.000 description 4
- 240000001624 Espostoa lanata Species 0.000 description 4
- 206010018852 Haematoma Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000015523 tannic acid Nutrition 0.000 description 3
- 229920002258 tannic acid Polymers 0.000 description 3
- 206010053567 Coagulopathies Diseases 0.000 description 2
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 2
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010041956 Stasis syndrome Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000005634 blind loop syndrome Diseases 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an externally applied traditional Chinese medicine for preventing and treating complications after needle withdrawal of a trocar, which is clinically used, and the traditional Chinese medicine for preventing subcutaneous hemorrhage after needle withdrawal mainly comprises the following raw material medicines in parts by weight: 10-20 g of pseudo-ginseng, 10-20 g of frankincense, 10-20 g of myrrh and 10-20 g of gallnut, grinding the components into fine powder, sieving the fine powder, and preparing the medicament by a conventional method after sterilization. The traditional Chinese medicine has the advantages of simple preparation, low cost, wide medicine source, convenient use, quick curative effect, high cure rate and no toxic or side effect.
Description
Technical field
The trocar that the present invention relates to clinical use pulls out the external Chinese medicine of pin infectious-related complication control, specifically a kind of Chinese medicine that prevents subcutaneous hemorrhage after pulling out needle.
Background technology
At present clinically in rescuing critical patient or operation process, all adopt the trocar to carry out administration, fluid infusion, blood transfusion.To old man, children's need supply the medicine over a long time person or venipuncture difficulty the greater, generally also all adopt the trocar to carry out administration, fluid infusion, blood transfusion.Use the trocar can avoid repeated localised puncture to bring misery, also be easy to fix to patient, movable unrestricted, often use clinically, make nursery work time saving and energy saving, the efficient height.Because the trocar is thick, during use, thick needle mechanical stimulus skin can cause that the pinprick place is hemorrhage, complication such as sepage or hematoma formation.
Summary of the invention
The objective of the invention is provides a kind of good effect, short treating period, cure rate height, and has no side effect in order to solve the deficiency of above-mentioned technology, can effectively prevent the Chinese medicine of subcutaneous hemorrhage after pulling out needle.
For achieving the above object, a kind of Chinese medicine that prevents subcutaneous hemorrhage after pulling out needle, it is characterized in that it mainly is made up of the component of following raw materials in weight drug ratio: Radix Notoginseng 10-20g, Olibanum 10-20g, Myrrha 10-20g, Galla Chinensis 10-20g grinds to the powder altogether and sieves, the medicament of making according to a conventional method after aseptic.
Chinese medicine preparation of the present invention is simple, and cost is low, the medicine source is wide, easy to use, and curative effect is fast, and the cure rate height is without any side effects.Dip in dry cotton ball during use and get a little medicamental pulverata and put the pinprick place and pull out pin, the reuse immobilization with adhesive tape only needs a short time to push and can stop blooding, and seepage-proof liquid, hematoma form, but and pain relieving, antiinflammatory is early healed.
The Radix Notoginseng of Chinese medicine of the present invention: bitter in the mouth, sweet, warm in nature, go into the Liver Channel blood system, kind hemostasis dissipating blood stasis is used for various hemorrhages.Have hemostasis not stay the stasis of blood, positive characteristics are not hindered in blood stasis dispelling.Clinical practice is hemorrhage, respond well in various wound hemorrhages, the treatment of fulgerizing, laser therapy, wound surface.Function: removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation.Chemical analysis: mainly contain Saponin and the ginsenoside is similar, also contain arasaponin and flavone compound, alkaloid, protein, sugar, fatty oil, resin, nucleoside, free amino acid, calcium ion etc.(after the Radix Notoginseng hydrolysis, main panaxatriol, panoxadiol).Anastalsis: the immersion fluid of Radix Notoginseng, Radix Notoginseng water extract (panaxatriol and panoxadiol) can shorten clotting time and prothrombing time and bring into play anastalsis.Analgesic activity: total Saponin of Radix Notoginseng and Radix Notoginseng total saponin from leaves have obvious analgesic activity.
Olibanum: acrid in the mouth hardship, warm in nature, GUIXIN liver spleen channel, clinical practice is in syndrome of qi stagnation and blood stasis, stagnate as traumatic injury, the stasis of blood and have a pain etc., when Olibanum and Myrrha have blood stasis to stay resistance to subcutaneous hemorrhage and retinal hemorrhage can with Radix Notoginseng with stopping blooding and do not stay the effect of the stasis of blood in order to play.Effect: blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain.The Olibanum analgesic effect is preferable, but both blood stasis dispelling, but pain relieving again.Same with Myrrha with declaring logical internal organs, dredging the meridian.Chemical analysis: resinous, gummy, volatile oil, boswellic acid, olibanoresene etc.Do not hold back mouth for a long time with the Myrrha external place of curing the wound that grinds to the powder altogether, congestion and swelling pain, respond well, and can strengthen invigorate blood circulation, blood stasis dispelling, analgesic activity.
Myrrha: nature and flavor hardship, flat.GUIXIN, liver, spleen channel.The merit of its promoting blood circulation and stopping pain is similar to Olibanum, and it is pain caused to be used for various blood-stasis syndromes, respond well.Apply and to control ulcer and do not hold back mouth for a long time with the Olibanum external that grinds to the powder altogether.Chemical analysis: resinous, gummy, volatile oil have inhibitory action to fungus.Effect: promoting blood circulation and stopping pain, detumescence and promoting granulation, clots absorbing pain relieving partially.
Galla Chinensis: nature and flavor: sour, salty, flat, go into lung, large intestine, kidney channel.This product is gone into blood system the astringing to arrest bleeding effect; External has detoxifcation, detumescence, removing dampness to hold back the effect of skin ulcer, the merit that reduces inflammatory exudation and convergence wound is arranged, sour and astringent convergence.Chemical analysis: containing a large amount of tannic acids (50-80%) has precipitation to protein, makes the protein coagulating of mucocutaneous ulcer become protection of one deck tunicle and convergence.Tannic acid and metal species alkaloid or glycoside form not dissolved compound and function of detoxification-a kind of antidote effect are arranged, and staphylococcus, streptococcus are had antibacterial, antiinflammation.
The present invention verifies through clinical practice, and a little is pushed pinprick when pulling out pin and both can stop blooding to dip in this medicamental pulverata with dry cotton ball when the trocar pulls out pin, can prevent again with reduce sepage ooze out and hematoma forms, total effective rate reaches 100%, obvious effective rate reaches 72%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment: the manufacture method of Chinese medicine of the present invention is: with Radix Notoginseng, Olibanum, Myrrha, each 10-20g of Galla Chinensis, grind to the powder altogether and sieve, the aseptic bottled sealing in back.Dip in dry cotton ball during use and get a little medicamental pulverata and put the pinprick place and pull out pin, the reuse immobilization with adhesive tape only needs a short time to push and can stop blooding, and seepage-proof liquid, hematoma form, but and pain relieving, antiinflammatory is early healed.The styptic activity material Dencichine of Radix Notoginseng (is a seed amino acid, be the strongest monomer of a kind of styptic activity), the clotting time of shortening and the haemostatic effect of prothrombing time are arranged, the Radix Notoginseng total arasaponins that contains has analgesic activity, and Radix Notoginseng goes into blood system, and merit is apt to hemostasis, blood stasis dispelling, tissue regeneration promoting, there is hemostasis not stay the characteristics of the stasis of blood, from the Ming Dynasty, Radix Notoginseng is cured house by the crowd and is considered as stasis-resolving hemostatic, and detumescence, pain relieving, tissue regeneration promoting effect are arranged; Olibanum, Myrrha and Radix Notoginseng compatibility have a hemostasis dissipating blood stasis analgesic effect to pinprick is hemorrhage; Galla Chinensis contains a large amount of tannic acids, has the astringing to arrest bleeding detoxifcation to hold back the effect of skin ulcer, so four kinds of medicine compatibilities have hemostasis, repercussive, convergence, pain relieving, antiinflammatory effect.
A kind of Chinese medicine clinical observation on the therapeutic effect data that prevents subcutaneous hemorrhage after pulling out needle
67 examples are used in clinical practice, when pulling out pin after the puncture, use the cotton balls that dips in Chinese medicine of the present invention to push and can stop blooding in point of puncture 1-2 minute.Do not occur ecchymosis, can not be hemorrhage once more.Untoward reaction appears in none example, proves that this prescription is reasonable, effective, safety.
Claims (1)
1, a kind of Chinese medicine that prevents subcutaneous hemorrhage after pulling out needle is characterized in that it mainly is made up of the component of following raw materials in weight drug ratio: Radix Notoginseng 10-20g, Olibanum 10-20g, Myrrha 10-20g, Galla Chinensis 10-20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100453308A CN100457136C (en) | 2006-06-30 | 2006-06-30 | Traditional Chinese medicine for preventing subcutaneous bleeding after needle withdrawal |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100453308A CN100457136C (en) | 2006-06-30 | 2006-06-30 | Traditional Chinese medicine for preventing subcutaneous bleeding after needle withdrawal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1899350A true CN1899350A (en) | 2007-01-24 |
| CN100457136C CN100457136C (en) | 2009-02-04 |
Family
ID=37655460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100453308A Expired - Fee Related CN100457136C (en) | 2006-06-30 | 2006-06-30 | Traditional Chinese medicine for preventing subcutaneous bleeding after needle withdrawal |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100457136C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102139029A (en) * | 2011-03-07 | 2011-08-03 | 山东盛宏医药科技有限公司 | External Chinese medicinal preparation for treating trauma and preparation method thereof |
| CN106138567A (en) * | 2016-07-30 | 2016-11-23 | 李秀军 | A kind of ointment preventing the trocar from extracting rear subcutaneous hemorrhage |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1223366C (en) * | 2002-11-09 | 2005-10-19 | 张生全 | Hemostat and its usage |
-
2006
- 2006-06-30 CN CNB2006100453308A patent/CN100457136C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102139029A (en) * | 2011-03-07 | 2011-08-03 | 山东盛宏医药科技有限公司 | External Chinese medicinal preparation for treating trauma and preparation method thereof |
| CN106138567A (en) * | 2016-07-30 | 2016-11-23 | 李秀军 | A kind of ointment preventing the trocar from extracting rear subcutaneous hemorrhage |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100457136C (en) | 2009-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102805792B (en) | Ointment for treating hemorrhoids and preparation method thereof | |
| CN102205020A (en) | Traditional Chinese medicine for treating traumatic injury | |
| CN100457136C (en) | Traditional Chinese medicine for preventing subcutaneous bleeding after needle withdrawal | |
| CN1304035C (en) | Paste for treating shank ulcer and bedsore | |
| CN108686103B (en) | Hemostatic traditional Chinese medicine composition and multifunctional emergency hemostatic composite material | |
| CN104840749B (en) | A kind of externally-applied ointment and preparation method treated skin trauma and be free of heavy metal | |
| CN111617189B (en) | Traditional Chinese medicine composition for treating dry skin chap | |
| CN111000794B (en) | Bletilla polysaccharide/bioglass temperature-sensitive gel and preparation method and application thereof | |
| CN109602854B (en) | Ointment for treating burns and scalds and preparation method thereof | |
| CN1246021C (en) | Non-scar plaster for treating trauma and its preparing process and usage | |
| CN101172129B (en) | Traditional Chinese medicine composition for treating subcutaneous ecchymosis and preparation method thereof | |
| CN1385193A (en) | Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration | |
| CN112220860A (en) | Traditional Chinese medicine protective plaster for internal arteriovenous fistula of uremia patient | |
| CN103655854B (en) | Treatment venous transfusion causes phlebitic application compress and using method | |
| CN104352696B (en) | A kind of Chinese medicine for treating wound and application thereof | |
| CN112190660A (en) | Traditional Chinese medicine composition for promoting wound healing and preparation method thereof | |
| CN109223931A (en) | A kind of burn cream and preparation method thereof for treating burn | |
| CN102526382A (en) | Plaster for relieving swelling and pain | |
| CN101869623B (en) | Medicament for treating trichoepithelioma and preparation method thereof | |
| CN1262300C (en) | Medicinal liquid for Hong Kong foot | |
| CN103989772A (en) | Traditional Chinese medicament for treating skin ulcer and reducing scar formation and preparation process thereof | |
| CN114796371A (en) | Medicine for treating diabetic complications | |
| CN101491626A (en) | Traditional Chinese medicine composition for treating skin injury and suppurative infection | |
| CN103800507A (en) | Compound skin ulcer resisting suspension and preparation method thereof | |
| CN1861117A (en) | High performance anidrotic umbilicus plaster |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090204 |